vytispharmaceuticals

Tranexavyt

Dosage form

Injectable

Packing

1 * 5 vials + tray 

Composition

Tranexamic acid 500 mg/5 ml

Pharmacological classification

Antifibrinolytic

 

Description

Tranexamic acid is a synthetic derivative of lysine used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. Tranexamic acid binds to the 5 lysine binding sites on plasminogen, inhibits plasmin formation, and displaces plasminogen from the fibrin surface during the physiological process of coagulation. 

Scroll to Top